Carcinoma: Latest News, Top Stories & Analysis

Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data

May 7, 2026May 7, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported additional Phase 2 trial data showing a dose-response relationship for its SkinJect treatment candidate for nodular basal cell carcinoma, with the …

Regional

Aprea Therapeutics Teams Up with MD Anderson for Preclinical HNSCC Research

March 13, 2025March 12, 2025 - by Timothy Alexander

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD Anderson Cancer Center to advance preclinical studies of its WEE1 kinase inhibitor, APR-1051. …